FIM
IONS icon

Foresters Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Foresters Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,889
Closed -$196K – 475
2017
Q4 		$196K Sell
3,889
-741
-16% -$40.6K ﹤0.01% 501
2017
Q3 		$235K Buy
4,630
+269
+6% +$14.1K ﹤0.01% 458
2017
Q2 		$222K Buy
+4,361
New +$203K ﹤0.01% 448

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Foresters Investment Management's IONS Position: Q1 2018 in Review

Foresters Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2018, closing a stake of 3,889 shares — an estimated $196K sold.

Foresters Investment Management first reported a position in IONS in Q2 2017 and held it in 3 quarters. The position peaked at $235K in Q3 2017. 325 funds tracked by Wall St. Rank hold IONS as of Q1 2018.

  • Foresters Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Foresters Investment Management sold 3,889 Ionis Pharmaceuticals shares in Q1 2018, an estimated $196K.
  • Foresters Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • Foresters Investment Management's Ionis Pharmaceuticals position peaked at $235K in Q3 2017.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2018.

Based on Foresters Investment Management's 13F filing for Q1 2018, filed 11 May 2018.